Dr. Brad Dickson, Van Andel Research Institute (IMAGE)
Caption
For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes in proteins and other critical regulatory factors across the genome. While ChIP-seq provides invaluable insights into the underpinnings of health and disease, it also faces a frustrating challenge: its results are often viewed as qualitative rather than quantitative, making interpretation difficult. But, it turns out, ChIP-seq may have been quantitative all along.
Credit
Courtesy of Van Andel Institute
Usage Restrictions
Please use attribution
License
Licensed content